NCT01293591

Brief Summary

This study is being done to study the healthful benefits of eating garlic. Previous studies suggest that garlic may help prevent cancer. The investigators are recruiting healthy volunteers to participate in a study to determine the ways in which eating garlic may reduce cancer risk.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2010

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2010

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2010

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

February 8, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 10, 2011

Completed
Last Updated

June 2, 2017

Status Verified

February 1, 2011

Enrollment Period

1 month

First QC Date

February 8, 2011

Last Update Submit

June 1, 2017

Conditions

Keywords

GarlicCancer biomarkersGene expressionOxidative stressDNA damage

Outcome Measures

Primary Outcomes (5)

  • Garlic metabolites

    Garlic metabolites will be measured in blood and urine.

    Day 11 of each treatment period -- before and 3 hours after treatment

  • Markers of gene expression

    Lymphocyte microarray analysis, lymphocyte DNA genotyping. Microarray results will be confirmed by RT-PCR.

    Day 11 of each treatment period -- before and 3 hours after treatment

  • DNA damage

    Comet assay, 8-oxo-dG, histone analysis

    Day 11 of each treatment period -- before and 3 hours after treatment

  • Oxidative stress

    Serum nitrate/nitrite, malondyaldehyde, glutathione, glutathione reductase, glutathione S-transferase, catalase, protein carbonyls, F2-isoprostanes.

    Day 11 of each treatment period -- before and 3 hours after treatment

  • Biomarkers of inflammation

    C-reactive protein (CRP), vascular endothelial growth factor, IL-1, IL-6, TNF-α.

    Day 11 of each treatment period -- before and 3 hours after treatment

Study Arms (2)

Control

OTHER

270 kcal White bread with 15 g margarine

Other: Control

Garlic Treatment

OTHER

270 kcal white bread with 15 g margarine and 5 g crushed garlic

Other: Garlic treatment

Interventions

ControlOTHER

Subjects will consume a garlic-free diet for 10 days. On day 11, subjects will consume 270 kcal white bread with 15 g margarine.

Control

Subjects will consume a garlic-free diet for 10 days. On day 11, subjects will consume 270 kcal white bread with 15 g margarine and 5 g crushed garlic.

Garlic Treatment

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 40-80 years

You may not qualify if:

  • Younger than 40 years old or older than 80 years old
  • Use of blood-thinning medications such as Coumadin (warfarin), Dicumarol (dicumarol), or Miradon (anisinidione)
  • Presence of kidney disease, liver disease, gout, certain cancers, thyroid disease, gastrointestinal, other metabolic diseases or malabsorption syndromes.
  • Have been pregnant during the previous 12 months, are currently pregnant or lactating, or plan to become pregnant during the study
  • Follicle stimulating hormone levels above 35 mIU/mL serum
  • Type 2 diabetes requiring the use of oral antidiabetic agents or insulin
  • History of eating disorders or other dietary patterns which are not consistent with the dietary intervention (e.g., vegetarians, very low fat diets, high protein diets)
  • Use of prescription or over-the-counter antiobesity medications or supplements (e.g., phenylpropanalamine, ephedrine, caffeine) during and for at least 6 months prior to the start of the study or a history of a surgical intervention for obesity
  • Active cardiovascular disease (such as a heart attack or procedure within the past three months or participation in a cardiac rehabilitation program within the last three months, stroke, or history/treatment for transient ischemic attacks in the past three months, or documented history of pulmonary embolus in the past six months).
  • Use of any tobacco products in past 6 months
  • Use of oral or IV antibiotics during the month preceding the study or during the study
  • Unwillingness to abstain from vitamin, mineral, and herbal supplements for two weeks prior to the study and during the study
  • Known (self-reported) allergy or adverse reaction to garlic
  • Inability to metabolize garlic
  • Unable or unwilling to give informed consent or communicate with study staff
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

USDA Beltsville Human Nutrition Research Center

Beltsville, Maryland, 20705, United States

Location

Related Publications (1)

  • Charron CS, Dawson HD, Albaugh GP, Solverson PM, Vinyard BT, Solano-Aguilar GI, Molokin A, Novotny JA. A Single Meal Containing Raw, Crushed Garlic Influences Expression of Immunity- and Cancer-Related Genes in Whole Blood of Humans. J Nutr. 2015 Nov;145(11):2448-55. doi: 10.3945/jn.115.215392. Epub 2015 Sep 30.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
FED
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Physiologist

Study Record Dates

First Submitted

February 8, 2011

First Posted

February 10, 2011

Study Start

July 1, 2010

Primary Completion

August 1, 2010

Study Completion

August 1, 2010

Last Updated

June 2, 2017

Record last verified: 2011-02

Data Sharing

IPD Sharing
Will not share

Locations